[
  {
    "title": "奥浦迈(688293.SH)：拟使用部分超募资金3亿元永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/12/29153937246201.shtml",
    "datetime": "2022-12-29 15:39:31",
    "code": "688293"
  },
  {
    "title": "奥浦迈2022年前三季度净利8309.12万同比增长79.97% 业务持续增长",
    "href": "http://stock.jrj.com.cn/2022/10/27111237088722.shtml",
    "datetime": "2022-10-27 11:12:20",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)：第三季度净利增9.28%至2973.46万元",
    "href": "http://stock.jrj.com.cn/2022/10/26154537085590.shtml",
    "datetime": "2022-10-26 15:45:38",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)：拟使用不超10亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2022/09/25170137019453.shtml",
    "datetime": "2022-09-25 17:01:42",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)：拟使用募集资金32143万元对奥浦迈生物工程进行增资、实施募投项目",
    "href": "http://stock.jrj.com.cn/2022/09/25165837019447.shtml",
    "datetime": "2022-09-25 16:58:16",
    "code": "688293"
  },
  {
    "title": "“细胞培养基第一股”奥浦迈登陆科创板，上市首日股价涨幅近60%",
    "href": "http://stock.jrj.com.cn/ipo/2022/09/02131336967059.shtml",
    "datetime": "2022-09-02 13:13:02",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293)：将于2022年9月2日在上海证券交易所科创板上市",
    "href": "http://stock.jrj.com.cn/2022/09/01090736961422.shtml",
    "datetime": "2022-09-01 09:07:31",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)：将于9月2日在科创板上市",
    "href": "http://stock.jrj.com.cn/2022/08/31201036959556.shtml",
    "datetime": "2022-08-31 20:10:31",
    "code": "688293"
  },
  {
    "title": "奥浦迈IPO竞争形势严峻研发投入持续下滑 募投项目产能消化存风险",
    "href": "http://stock.jrj.com.cn/2022/08/30110636952042.shtml",
    "datetime": "2022-08-30 11:06:00",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293)：披露网上发行中签结果,末“5”位数：88358,38358",
    "href": "http://stock.jrj.com.cn/2022/08/26090636939048.shtml",
    "datetime": "2022-08-26 09:06:43",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)：网上发行最终中签率为0.03293174%",
    "href": "http://stock.jrj.com.cn/2022/08/24202936931976.shtml",
    "datetime": "2022-08-24 20:29:38",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293)：发行价格确定80.20元/股，发行日期2022年8月24日（T日）",
    "href": "http://stock.jrj.com.cn/2022/08/23091336924011.shtml",
    "datetime": "2022-08-23 09:13:12",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293.SH)IPO定价为80.20元/股、8月24日申购",
    "href": "http://stock.jrj.com.cn/2022/08/22192336922671.shtml",
    "datetime": "2022-08-22 19:23:26",
    "code": "688293"
  },
  {
    "title": "奥浦迈(688293)：首发2049.5082万股，询价日期为2022年8月19日周五",
    "href": "http://stock.jrj.com.cn/2022/08/16091636902969.shtml",
    "datetime": "2022-08-16 09:16:12",
    "code": "688293"
  },
  {
    "title": "奥浦迈即将上会：主要客户的创始人与公司实控人系前同事 累计采购金额超2000万",
    "href": "http://stock.jrj.com.cn/2022/04/12121236313710.shtml",
    "datetime": "2022-04-12 12:12:28",
    "code": "688293"
  },
  {
    "title": "两轮问询回复后迎上会，奥浦迈4月13日科创板IPO接受上市审核",
    "href": "http://stock.jrj.com.cn/2022/04/07092736266747.shtml",
    "datetime": "2022-04-07 09:27:39",
    "code": "688293"
  },
  {
    "title": "重大诉讼或仲裁等19个问题遭连环问，奥浦迈答科创板首轮问询",
    "href": "http://stock.jrj.com.cn/2022/02/28100934495659.shtml",
    "datetime": "2022-02-28 10:09:04",
    "code": "688293"
  },
  {
    "title": "奥浦迈冲刺科创板IPO，如何破解下游客户产品研发失败或无法产业化风险？",
    "href": "http://stock.jrj.com.cn/2021/11/24090533912978.shtml",
    "datetime": "2021-11-24 09:05:41",
    "code": "688293"
  },
  {
    "title": "海通证券辅导，奥浦迈生物拟A股IPO",
    "href": "http://stock.jrj.com.cn/2021/02/09144831877222.shtml",
    "datetime": "2021-02-09 14:48:22",
    "code": "688293"
  },
  {
    "title": "奥浦迈生物获近亿元战略投资 将提升细胞培养基产能",
    "href": "http://stock.jrj.com.cn/2018/04/19165424417864.shtml",
    "datetime": "2018-04-19 16:54:00",
    "code": "688293"
  }
]